<DOC>
	<DOCNO>NCT01023620</DOCNO>
	<brief_summary>This study do well understand people HIV take drug HIV begin show abnormal change fat loss fat gain body . This condition call lipodystrophy . Patients take medicine HIV lipodystrophy report loss subcutaneous ( sc ) fat arm , leg , face excess fat gain neck truncal region . They also likely problem insulin body , high fat level blood diabetes . The reason lipodystrophy develop fully understood although HIV drug likely cause . The complication pose increase risk fat blockage form artery make risk heart problem future . Changes body fat cause physical discomfort psychological distress . Management problem challenge patient 's doctor . The investigator propose data collection determine one reason might happen people others . Laboratory sample collect : 1 ) special image liver ; 2 ) fat collect needle mid thigh mid-shoulder area ; 3 ) blood sample measure virus , t-cells , fat , marker patient 's body handle virus . This study do science fully understand patient HIV take medicine virus abnormal fat loss gain . This research study intend help u good understand happens .</brief_summary>
	<brief_title>HIV Acquired Lipodystrophy ( HAL ) Classification , Measurement Fat Response Thiazolidinedione ( TZD ) ( Pioglitazone )</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Lipodystrophy</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>2,4-thiazolidinedione</mesh_term>
	<criteria>Participants must 18 year age older racial ethnic origin , capable give informed consent . Spanish speaking individual eligible participation . Additionally must be/have : 1 . Biologically male ( transgendered ) 2 . HIV positive least 24 month , 3 . On stable HAART least last 3 month prior enter study , 4 . Practitioner diagnose lipodystrophy define : aHAL ( ) decrease subcutaneous fat limb prominent vein , loss buttock fat facial atrophy hHAL : fat accumulation abdomen and/or dorsocervical region Participants le 18 year age , institutionalize , prior disease condition may alter body fat composition . Exclusions : 1 . Females exclude 2 . Prior history CHF 3 . Prior history macular retinal edema 4 . Prior history spontaneous bone fracture 5 . Diabetics receive oral/injected/inhaled diabetic agent individual fast blood glucose value great equal 140 within last 90 day . 6 . Current active opportunistic infection example : 1 . PCP pneumonia 2 . Neuropathy 3 . Thrush 4 . Systemic KS ( Kaposi sarcoma ) ) localize cutaneous lesion exclusion e ) MAC ( Mycobacterium Avium complex ) f ) Histoplasmosis g ) Coccidioidomycosis 7 . Planning discontinue HAART 8 . Current diagnosis cancer receive chemotherapy 9 . Systemic steroid use prior 6 month 10 . Hepatitis C+ previous diagnosis cirrhosis 11 . Liver Function Studies great equal triple normal value</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>HIV</keyword>
	<keyword>Lipodystrophy</keyword>
	<keyword>Lipoatrophy</keyword>
	<keyword>Lipohypertrophy</keyword>
	<keyword>Human Immunodeficiency Virus</keyword>
</DOC>